FDA: J&J delayed reporting insulin pump problems
Wednesday, January 11, 2012 - 17:00
in Health & Medicine
(AP) -- Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who were using its OneTouch Ping and 2020 pumps.